–CancerVision designed to democratize fast, affordable cancer analysis and diagnosis with broadened access to complete genomic information– –Company opened San Diego-based corporate...read more
Category - Clinical genetics
Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service
As clinical whole-genome sequencing (WGS) is becoming more of a routine diagnostic test for certain patients with genetic disorders, the Broad Institute has launched a new end-to-end WGS and variant interpretation...read more
Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine
My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more
Goodbye 2022 – Hello 2023
We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more
